Arto Urtti
Arto Urtti
Email verificata su
Citata da
Citata da
Challenges and obstacles of ocular pharmacokinetics and drug delivery
A Urtti
Advanced drug delivery reviews 58 (11), 1131-1135, 2006
Current and future ophthalmic drug delivery systems: a shift to the posterior segment
EM Del Amo, A Urtti
Drug discovery today 13 (3-4), 135-143, 2008
Ocular absorption following topical delivery
K Järvinen, T Järvinen, A Urtti
Advanced drug delivery reviews 16 (1), 3-19, 1995
Microemulsions for topical delivery of estradiol
S Peltola, P Saarinen-Savolainen, J Kiesvaara, TM Suhonen, A Urtti
International journal of pharmaceutics 254 (2), 99-107, 2003
Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies
M Ruponen, S Ylä-Herttuala, A Urtti
Biochimica et Biophysica Acta (BBA)-Biomembranes 1415 (2), 331-341, 1999
Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations
TM Suhonen, JA Bouwstra, A Urtti
Journal of controlled release 59 (2), 149-161, 1999
Proniosome based transdermal delivery of levonorgestrel for effective contraception
B Vora, AJ Khopade, NK Jain
Journal of controlled release 54 (2), 149-165, 1998
Nanofibrillar cellulose hydrogel promotes three-dimensional liver cell culture
M Bhattacharya, MM Malinen, P Lauren, YR Lou, SW Kuisma, L Kanninen, ...
Journal of controlled release 164 (3), 291-298, 2012
Drug transport in corneal epithelium and blood–retina barrier: emerging role of transporters in ocular pharmacokinetics
E Mannermaa, KS Vellonen, A Urtti
Advanced drug delivery reviews 58 (11), 1136-1163, 2006
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
EM del Amo, A Urtti, M Yliperttula
European Journal of Pharmaceutical Sciences 35 (3), 161-174, 2008
Cell culture models of the ocular barriers
M Hornof, E Toropainen, A Urtti
European journal of pharmaceutics and biopharmaceutics 60 (2), 207-225, 2005
Gold nanoparticles enable selective light-induced contents release from liposomes
L Paasonen, T Laaksonen, C Johans, M Yliperttula, K Kontturi, A Urtti
Journal of controlled release 122 (1), 86-93, 2007
Interaction of liposomes with human skin in vitro—the influence of lipid composition and structure
M Kirjavainen, A Urtti, I Jääskeläinen, TM Suhonen, P Paronen, ...
Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1304 (3 …, 1996
Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
KM Hämäläinen, K Kananen, S Auriola, K Kontturi, A Urtti
Investigative ophthalmology & visual science 38 (3), 627-634, 1997
Minimizing systemic absorption of topically administered ophthalmic drugs
A Urtti, L Salminen
Survey of ophthalmology 37 (6), 435-456, 1993
Structure–activity relationships of poly (L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery
M Männistö, S Vanderkerken, V Toncheva, M Elomaa, M Ruponen, ...
Journal of controlled release 83 (1), 169-182, 2002
Comparison of cell proliferation and toxicity assays using two cationic liposomes
K Lappalainen, I Jääskeläinen, K Syrjänen, A Urtti, S Syrjänen
Pharmaceutical research 11 (8), 1127-1131, 1994
Effect of liposomal and free bisphosphonates on the IL-1β, IL-6 and TNFα secretion from RAW 264 cells in vitro
N Pennanen, S Lapinjoki, A Urtti, J Mönkkönen
Pharmaceutical research 12 (6), 916-922, 1995
Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity
L Pitkänen, VP Ranta, H Moilanen, A Urtti
Investigative ophthalmology & visual science 46 (2), 641-646, 2005
Pharmacokinetic aspects of retinal drug delivery
EM Del Amo, AK Rimpelä, E Heikkinen, OK Kari, E Ramsay, T Lajunen, ...
Progress in retinal and eye research 57, 134-185, 2017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20